37
Adverse Events & Serious Adverse Events 1 08/22/22 Katalyst Healthcares & Life Sciences

Adverse Events and Serious Adverse Events - Katalyst HLS

Embed Size (px)

Citation preview

Page 1: Adverse Events and Serious Adverse Events - Katalyst HLS

Adverse Events &

Serious Adverse Events

1

05/02/23Katalyst Healthcares & Life Sciences

Page 2: Adverse Events and Serious Adverse Events - Katalyst HLS

Objectives:

Recognize Adverse Events and Serious Adverse Events Review FDA inspection findings related to Adverse

Events Review regulations related to Adverse Events Discuss recording and reporting of Adverse Events Discuss auditing of Adverse Events Demonstrate audit of Adverse Events

2

05/02/23

Katalyst Healthcares & Life Sciences

Page 3: Adverse Events and Serious Adverse Events - Katalyst HLS

FDA Inspection:

“Failure to prepare and submit complete and accurate and timely reports of unanticipated adverse device effects”

3

05/02/23Katalyst Healthcares & Life Sciences

Page 4: Adverse Events and Serious Adverse Events - Katalyst HLS

Recognizing:4

05/02/23Katalyst Healthcares & Life Sciences

Page 5: Adverse Events and Serious Adverse Events - Katalyst HLS

Adverse Events:

Any adverse event associated with the use of a drug in humans, whether or not considered related. 21CFR 314.80

Any untoward medical occurrence in a patient administered a pharmaceutical product and which does not necessarily have a causal relationship with the treatment ICH E6

5

05/02/23Katalyst Healthcares & Life Sciences

Page 6: Adverse Events and Serious Adverse Events - Katalyst HLS

Adverse Event:

NCI An unexpected medical problem that occurs during

treatment with a drug or other therapy. Adverse events do not have to be a caused by the

drug or therapy

6

05/02/23Katalyst Healthcares & Life Sciences

Page 7: Adverse Events and Serious Adverse Events - Katalyst HLS

Serious Adverse Event:

Fred Doesn’t Have Any Money Left

FatalDisabilityHospitalizationAnomalyMedically SignificantLife Threatening

7

05/02/23Katalyst Healthcares & Life Sciences

Page 8: Adverse Events and Serious Adverse Events - Katalyst HLS

Expected Vs. Unexpected

Expected Known to Occur and

is Listed in the Investigational Brochure, Informed Consent, or General Investigational Plan

Unexpected Not listed in

Investigational Brochure, Informed Consent, or General Investigational Plan

Also not listed in a drug package insert

8

05/02/23Katalyst Healthcares & Life Sciences

Page 9: Adverse Events and Serious Adverse Events - Katalyst HLS

Recording:

9

05/02/23Katalyst Healthcares & Life Sciences

Page 10: Adverse Events and Serious Adverse Events - Katalyst HLS

Recording:

Know which adverse events the protocol requires to be captured

10

05/02/23Katalyst Healthcares & Life Sciences

Page 11: Adverse Events and Serious Adverse Events - Katalyst HLS

Source Documentation:

Source Documentation of adverse events include documentation in the medical records of: Event Date it occurred Grade as determined by CTCAE Expected or Unexpected Attribution as assigned by PI Date resolved Treatment patient received specifically related to event

11

05/02/23Katalyst Healthcares & Life Sciences

Page 12: Adverse Events and Serious Adverse Events - Katalyst HLS

Sample Adverse Event Recording Form

See template behind this presentation

12

05/02/23Katalyst Healthcares & Life Sciences

Page 13: Adverse Events and Serious Adverse Events - Katalyst HLS

13

05/02/23Katalyst Healthcares & Life Sciences

Page 14: Adverse Events and Serious Adverse Events - Katalyst HLS

Attribution (Causality) The attribution (relationship or causality or drug

related assessment) must be determined

A determination made by a clinical investigator that describes the relationship or association of the study product with an adverse experience

This determination must be recorded both in the medical record as well as in the case report form.

14

05/02/23Katalyst Healthcares & Life Sciences

Page 15: Adverse Events and Serious Adverse Events - Katalyst HLS

Attribution

What should the investigator consider prior to assigning attribution? Individual medical history Known effects of concomitant medications

15

05/02/23Katalyst Healthcares & Life Sciences

Page 16: Adverse Events and Serious Adverse Events - Katalyst HLS

Attribution:

Definite – Clearly related to study agent Probable – Likely related to study agent Possible – May be related to study agent Unlikely – Doubtfully related to study agent Unrelated – Clearly not related to study

agent

16

05/02/23Katalyst Healthcares & Life Sciences

Page 17: Adverse Events and Serious Adverse Events - Katalyst HLS

How to Capture Adverse Events?

Split or Lumped Fever, Diarrhea, and Vomiting (Viral

Gastroenteritis) Cough, Sniffles, Sore throat (Flu)

17

05/02/23Katalyst Healthcares & Life Sciences

Page 18: Adverse Events and Serious Adverse Events - Katalyst HLS

How to Capture Adverse Events?

Problems with similar terms Rash or Dermatitis Wheezing, reactive airway disease,

congestion, cold, , asthma

18

05/02/23Katalyst Healthcares & Life Sciences

Page 19: Adverse Events and Serious Adverse Events - Katalyst HLS

Documenting Resolution Dates:

Challenge Does the patient remember when their adverse

event resolved? Do you call the patient? Or wait till the next visit?

19

05/02/23Katalyst Healthcares & Life Sciences

Page 20: Adverse Events and Serious Adverse Events - Katalyst HLS

Patient Toxicity Diary:

Diaries where patients capture toxicities between their follow up appointments

20

05/02/23Katalyst Healthcares & Life Sciences

Page 21: Adverse Events and Serious Adverse Events - Katalyst HLS

Patient Toxicity Diaries:

Patient writes down constipation because he did not have a bowel movement one day Research nurse captures constipation without assessing

further Physician copies the research nurse’s note and also dictates

constipation Did anyone ask about the constipation?

According to CTC V3, constipation is grade 1 only if there is occasional or intermittent symptoms; occasional use of stool softeners, laxatives, dietary modification, or enema

21

05/02/23Katalyst Healthcares & Life Sciences

Page 22: Adverse Events and Serious Adverse Events - Katalyst HLS

Patient Adverse Event Diaries:

Advantages Allows capturing

information on a daily basis while patient is away from clinic

A communication tool for patient returns to clinic

Useful in capturing onset and resolution dates of adverse events

Disadvantages Time consuming Patient non-compliance Patient self diagnosis or

interpretation Complicated Instructions

22

05/02/23Katalyst Healthcares & Life Sciences

Page 23: Adverse Events and Serious Adverse Events - Katalyst HLS

Question to Ask:

When should site staff begin collecting adverse event information?

23

05/02/23Katalyst Healthcares & Life Sciences

Page 24: Adverse Events and Serious Adverse Events - Katalyst HLS

Question to Ask:

How long should one collect adverse events after the subject completes study treatment?

24

05/02/23Katalyst Healthcares & Life Sciences

Page 25: Adverse Events and Serious Adverse Events - Katalyst HLS

Reporting:25

05/02/23Katalyst Healthcares & Life Sciences

Page 26: Adverse Events and Serious Adverse Events - Katalyst HLS

Reporting Serious Events

An investigator must promptly report to the sponsor any adverse effect that may reasonably be regarded as caused by or probably caused by the drug. If the adverse effect is alarming, the investigator shall report the adverse effect immediately. 21CFR312.64

26

05/02/23Katalyst Healthcares & Life Sciences

Page 27: Adverse Events and Serious Adverse Events - Katalyst HLS

Reporting Criteria:

Routine Reporting Know which events can be reported at

interim analysis or annual reviews Expedited Reporting

Know which events require immediate reporting

27

05/02/23Katalyst Healthcares & Life Sciences

Page 28: Adverse Events and Serious Adverse Events - Katalyst HLS

Reporting Criteria

Know which type of expedited reports each regulatory body requires FDA Sponsor Co-Sponsor MD Anderson NCI Collaborative Groups

28

05/02/23Katalyst Healthcares & Life Sciences

Page 29: Adverse Events and Serious Adverse Events - Katalyst HLS

Issues in Reporting:

Primary events Example

Patient admitted with Congestive Heart Failure Subsequently develops: Pulmonary Edema and

Cardiogenic Shock

29

05/02/23Katalyst Healthcares & Life Sciences

Page 30: Adverse Events and Serious Adverse Events - Katalyst HLS

Consequences of Improper Reporting

Protocol Violations IRB will close protocol FDA Hold Sponsor Hold Research Privileges Revoked Patient Safety

30

05/02/23Katalyst Healthcares & Life Sciences

Page 31: Adverse Events and Serious Adverse Events - Katalyst HLS

Auditing:

31

Page 32: Adverse Events and Serious Adverse Events - Katalyst HLS

Auditing Check Points

Was the event a dose limiting toxicity? Should the dose have been reduced? If so, did the research team realize it as such and

identify it correctly?

32

05/02/23Katalyst Healthcares & Life Sciences

Page 33: Adverse Events and Serious Adverse Events - Katalyst HLS

Auditing Check Points

How are AEs being recorded in the medical record?

Does documentation include grade, onset, resolution, and attribution?

33

05/02/23Katalyst Healthcares & Life Sciences

Page 34: Adverse Events and Serious Adverse Events - Katalyst HLS

Auditing Check Points

Were all toxicities included? Was the proper CTCAE version used for

the protocol? Were the toxicities graded

appropriately?

34

05/02/23Katalyst Healthcares & Life Sciences

Page 35: Adverse Events and Serious Adverse Events - Katalyst HLS

Auditing

Are adverse events appropriately reported within the time periods required by regulations, sponsor, and IRB policies?

35

05/02/23Katalyst Healthcares & Life Sciences

Page 36: Adverse Events and Serious Adverse Events - Katalyst HLS

We have reviewed……….

Recognizing adverse events and serious adverse events Inspections and findings related to adverse events Regulations related to adverse events Recording and reporting of adverse events Auditing of adverse events

36

05/02/23Katalyst Healthcares & Life Sciences

Page 37: Adverse Events and Serious Adverse Events - Katalyst HLS

Thank YouThank You&&

QuestionsQuestions

05/02/23

Contact:Katalyst Healthcare’s & Life SciencesSouth Plainfield, NJ, USA 07080.E-Mail: [email protected]

37